GeoVax Labs (GOVX) Total Current Liabilities (2010 - 2026)
GeoVax Labs (GOVX) posted quarterly Total Current Liabilities of $2.7 million for Q2 2026, up 7.25% year-over-year from $2.5 million in Q2 2025, and up 40.06% quarter-over-quarter from $1.9 million in Q4 2025.
GeoVax Labs (GOVX) Total Current Liabilities (2010 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Total Current Liabilities for 17 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 7.25% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $2.7 million (up 7.25% YoY), while the FY2025 annual figure was $1.9 million, down 37.67% from the prior year.
- Total Current Liabilities rose to $2.7 million in Q2 2026 per GOVX's latest filing, from $1.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $7.1 million in Q3 2023 and bottomed at $1.8 million in Q3 2025.
- Historically, Total Current Liabilities has averaged $3.7 million across 5 years, with a median of $3.4 million in 2022.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 1326.9% — and 2024, when it sank 63.17%.
- GeoVax Labs' Total Current Liabilities stood at $4.7 million in 2022, then slipped by 25.86% to $3.5 million in 2023, then dropped by 11.72% to $3.1 million in 2024, then tumbled by 37.67% to $1.9 million in 2025, then soared by 40.06% to $2.7 million in 2026.
- Business Quant data shows GOVX's Total Current Liabilities at $2.7 million in Q2 2026, $1.9 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Dec 31, 2024 | 3.11 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 7.08 Mn |
| Jun 30, 2023 | 4.09 Mn |
| Mar 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 4.75 Mn |
| Sep 30, 2022 | 4.79 Mn |
| Jun 30, 2022 | 3.37 Mn |
| Mar 31, 2022 | 3.50 Mn |
| Dec 31, 2021 | 5.44 Mn |
| Sep 30, 2021 | 335,650.00 |
| Jun 30, 2021 | 359,022.00 |